Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001111369) titled 'Bacterial mucosal immunotherapy for prevention of lower respiratory tract infections in preterm born infants- AUSTRALIA (BALLOON-AU)' on Sept. 8.
Study Type: Interventional
Study Design:
Purpose: Prevention
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Primary Sponsor: The Kids Research Institute Australia
Condition:
Lower Respiratory Tract Infections
Lower Respiratory Tract Infections
Respiratory - Other respiratory disorders / diseases
Intervention:
Bactek (MV130, Inmunotek, Spain)
MV130 is a mucosal bacterial immunotherapy (under the brand name of BACTEK(R) or Bacmune(R)),...